Two-Period Dynamic versus Fixed-Ratio Pricing Policies under Duopoly Competition

被引:4
|
作者
Li, Hao [1 ,2 ]
Yang, Xi [1 ]
Tu, Yu [1 ]
Peng, Ting [1 ]
机构
[1] Chongqing Jiaotong Univ, Sch Econ & Management, Chongqing 400074, Peoples R China
[2] Western China Transportat Econ Soc Dev Studies Ct, Chongqing 400074, Peoples R China
基金
中国国家自然科学基金;
关键词
Competition model - Dynamic pricing - Equilibrium profits - Intertemporal utility maximization - Optimal pricing - Perishable product - Pricing policy;
D O I
10.1155/2019/6567952
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
This paper introduces a two-period, pricing policy under duopoly competition between two firms offering an identical product to consumers who are intertemporal utility maximization. Firms have equal inventories of faultlessly replaceable and perishable products. The firms adjust prices to maximize profits and determine optimal pricing policies, choosing from dynamic pricing, fixed-ratio pricing, and elastic pricing policies. According to a duopoly competition model, the consumer is limited to a single firm visit per period. The consumer decides to purchase the product at current price from a firm and remain in the market to purchase product from the other firm in the next period or exit the market. The results offer three main conclusions. First, elastic pricing is consistent with dynamic pricing. Second, the more consumers visit the firm in the first period, the more profits the firm will make. Third, we explore the effectiveness of different pricing policies. The results show that although dynamic pricing is a more complex policy than fixed-ratio pricing, it may lead to decreased equilibrium profits when the firms sharply discounts prices and consumer rationality is unlimited.
引用
收藏
页数:11
相关论文
共 27 条
  • [21] A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted condition
    Kit Yee Cheah
    Kar Yee Mah
    Lai Hui Pang
    Shi Min Ng
    Jia Woei Wong
    Siew Siew Tan
    Hong Zhe Tan
    Kah Hay Yuen
    BMC Pharmacology and Toxicology, 21
  • [22] Bioavailability study of fixed-dose tablet versus capsule formulation of amlodipine plus benazepril: A randomized, single-dose, two-sequence, two-period, open-label, crossover study in healthy volunteers
    Chien, KL
    Chao, CL
    Su, TC
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (02): : 69 - 79
  • [23] Pharmacokinetics of a Fixed-Dose Combination of Mitiglinide and Metformin versus Concurrent Administration of Individual Formulations in Healthy SubjectsA Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover Study
    Jin Ah Jung
    Jung-Ryul Kim
    Suk-Ran Kim
    Tae-Eun Kim
    Soo-Youn Lee
    Jae-Wook Ko
    Wooseong Huh
    Clinical Drug Investigation, 2012, 32 : 799 - 804
  • [24] Pharmacokinetics of a Fixed-Dose Combination of Mitiglinide and Metformin versus Concurrent Administration of Individual Formulations in Healthy Subjects A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover Study
    Jung, Jin Ah
    Kim, Jung-Ryul
    Kim, Suk-Ran
    Kim, Tae-Eun
    Lee, Soo-Youn
    Ko, Jae-Wook
    Huh, Wooseong
    CLINICAL DRUG INVESTIGATION, 2012, 32 (12) : 799 - 804
  • [25] Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study
    Kandhwal, Kirti
    Dey, Surajit
    Nazarudheen, Shabana
    Arora, Rachna
    Reyar, Simrit
    Thudi, Nageshwar R.
    Monif, Tausif
    Singh, Manoj K.
    Rao, Shireen
    CLINICAL DRUG INVESTIGATION, 2011, 31 (12) : 853 - 863
  • [26] Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual FormulationsA Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study
    Kirti Kandhwal
    Surajit Dey
    Shabana Nazarudheen
    Rachna Arora
    Simrit Reyar
    Nageshwar R. Thudi
    Tausif Monif
    Manoj K. Singh
    Shireen Rao
    Clinical Drug Investigation, 2011, 31 : 853 - 863
  • [27] Comparison of the Bioavailability and Tolerability of Fixed-Dose Combination Glimepiride/Metformin 2/500-mg Tablets Versus Separate Tablets: A Single-Dose, Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Korean Volunteers
    Gu, Namyi
    Kim, Bo-Hyung
    Rhim, HyouYoung
    Chung, Jae-Yong
    Kim, Jung-Ryul
    Shin, Hyun-Suk
    Yoon, Seo-Hyun
    Cho, Joo-Youn
    Shin, Sang-Goo
    Jang, In-Jin
    Yu, Kyung-Sang
    CLINICAL THERAPEUTICS, 2010, 32 (07) : 1408 - 1418